The Intravascular Cooling in the Treatment of Stroke 2/3 Trial

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 120 participants.

Also called NCT01123161

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01123161
Other papers using this trial's data
  • Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2) Stroke, 2016-12 DOI, PubMed 27834742, PMC5134910 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Switzerland (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01123161. Randomized; single masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2015-01 (actual). Results posted on 2017-04-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Acronym
ICTuS2/3
Condition
Stroke, Acute
Intervention (Device)
hypothermia and anti-shivering treatment
Intervention (Drug)
Group1: IV t-PA and normothermia
Lead sponsor
University of California, San Diego (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)
Collaborator
The University of Texas Health Science Center, Houston (class: other)

Record details

Record id
cardio:ct-nct01123161
Content hash
a38a6e9bd9c450667e6f0ca0632503eb4ed19e648c3c00474ab48c04b0c92b57